Background Approximately 1% to 2% of all hospitalized children receive a transfusion of
blood products, in Germany as in other countries. High-quality scientific evidence on …

Critically ill children commonly receive coagulant products (plasma and/or platelet
transfusions) to prevent or treat hemorrhage or correct coagulopathy. Unique aspects of …

Abstract Background The Recipient Epidemiology and Donor Evaluation Study‐IV‐Pediatric
(REDS‐IV‐P) is a new iteration of prior National Heart, Lung, and Blood Institute (NHLBI) …

Objectives To evaluate whether implementing more restrictive neonatal intensive care unit
(NICU) platelet transfusion guidelines following the Platelets for Neonatal Transfusion-Study …

Objectives: To present a list of high-priority research initiatives for the study of plasma and
platelet transfusions in critically ill children from the Transfusion and Anemia EXpertise …

Objective: to analyze pediatric patient safety in the administration of blood components.
Method: a documentary and retrospective study, developed at a hospital in the Brazilian …

Background Major bleeding in patients undergoing therapeutic plasma exchange (TPE) has
been studied in large databases; but without standardizing bleeding definitions. Therefore …

Two high-quality studies confirmed that the use of restrictive transfusion triggers in preterm
infants in the intensive care unit (ICU) is reasonable and feasible. Unfortunately, no recent …

Background Blood centers play a critical role in supporting neonatal and pediatric
transfusions. We aim to study the variation in pediatric/neonatal transfusion policies and …

Red blood cell (RBC) transfusions are a common intervention in pediatric surgeries, with
10.1% of all pediatric procedures requiring a transfusion [1]. Transfusions serve to prevent …